TSPAN32 and B-cell chronic lymphocytic leukemia: Importantly, our results indicate that TSPAN32 downregulation is not restricted to T-ALL, as reduced expression was also observed in B-ALL and chronic lymphocytic leukemia (CLL), highlighting a broader pattern of suppression that transcends specific lymphoid lineages.